Key Highlights
- newcleo (NASDAQ:NWCL) was trading down 6.9% at USD 3.51 on Thursday, November 19, 2026, in intraday market data, implying a prior close near USD 3.77 (calculated), against a USD 4.01 close on November 17.
- Cash was 233.4 million euros at September 30, 2026, up from 90.4 million euros a year earlier, while Revenue from products and services rose about 26% to 9.95 million euros.
- A prospectus supplement dated November 18, 2026 covers up to 217,834,936 ordinary shares and 9,146,717 shares underlying warrants, against 281.5 million shares outstanding at September 30, 2026.
- The company said its commercial pipeline reached 10 gigawatts of later-stage projects within about 27 gigawatts across six countries, and it announced no new financing in the update.
Q3 Update and a New Prospectus Supplement Land Together
newcleo (NASDAQ:NWCL) was trading down 6.9% at USD 3.51 on November 19, 2026. On November 18, 2026 the company issued its third-quarter Business update and filed a prospectus supplement that covers up to 217,834,936 ordinary shares and 9,146,717 shares underlying warrants. The filing states no offering price and lists only the November 17 Nasdaq closing prices of USD 4.01 for the shares and USD 0.38 for the warrants. The excerpt reviewed did not label the registration, but such a filing lets holders sell registered shares, and the 217.8 million figure equals about 77% of shares outstanding (calculated). No company announcement explaining the day's move was found.
What the Nuclear Developer Reported for the Third Quarter
newcleo develops advanced modular reactors cooled by liquid lead, together with fuel made from recycled nuclear material, and employs more than 900 people in Europe and the United States. Revenue from products and services was 9.95 million euros against 7.9 million euros a year earlier. Other income fell about 75% to 2.9 million euros because a prior-year grant ended, and tangible Capital spending was 11.3 million euros. No net loss figure was disclosed in the update. The company listed on Nasdaq on September 22, 2026 after merging with a special purpose Acquisition company, raising about USD 247 million at closing, including a USD 216 million private placement.
Demonstrator Timeline, Resale Overhang and Thin-Trading Risk
The company expects to finish the primary system of its 10 megawatt thermal non-nuclear demonstrator in Italy and begin melting lead by the end of 2026. Commissioning is due to start in December and conclude in mid-2027, with first experimental data at the start of the second quarter of 2027. The company also closed the acquisition of Bonifait Pesage, a French maker of nuclear-grade weighing equipment, on November 2, 2026. The main risks are a large block of registered shares reaching the market, revenue that is still small against the cash burn implied by capital spending, schedule slippage and licensing. A low-priced, recently listed share can see wide spreads, and a small number of trades can move the price.
Where Things Stand
Possibly, but the slide has no announced company cause. newcleo (NASDAQ:NWCL) showed rising cash and revenue, and no new financing, while the same day brought a prospectus covering a large share of the float, which may weigh on sentiment (an observation, not a stated reason). The implied prior close of USD 3.77 (calculated) was already below the USD 4.01 November 17 close. Next markers are the start of demonstrator commissioning in December 2026, any holder selling reported in filings, and the first-quarter 2027 data timeline.






Please wait processing your request...